QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,036 signal articles · 531 in last 24h · 103,484 total before filter · latest 14m ago
531last 24h
2514last 7d
484● bullish (7d)
257● bearish (7d)
197publishers
AllMacro243Earnings1482M&A141Regulatory16Product4Analyst29
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Wall Street Extends Record-Setting Stock Rally
Barrons.com1h agobullish
Wall Street Extends Record-Setting Stock Rally

Stocks kicked off Wednesday's session higher, extending the week's broad rally. The S&P 500 was on pace to set another record high, up 0.6%. The Dow Jones Industrial Average rose 1.1% or 600 points, also on track for a fresh record.

Shopify shares surge after strong Q2 results and upbeat outlook
InvestorsHub1h agobullish
Shopify shares surge after strong Q2 results and upbeat outlook

Shopify (NASDAQ:SHOP) soared in pre-market trading on Wednesday after delivering second-quarter results that comfortably exceeded Wall Street expectations, with strong revenue growth, higher profitability and an optimistic outlook for the months ahead. Shares jumped around 26% before the opening bell as investors welcomed accelerating momentum across the company’s core business.

Kraft Heinz beats Q2 estimates and lifts 2026 outlook
InvestorsHub1h agobullish
Kraft Heinz beats Q2 estimates and lifts 2026 outlook

Kraft Heinz (NASDAQ:KHC) traded slightly lower in pre-market trading on Wednesday despite reporting second-quarter results that exceeded market expectations and improving its full-year outlook. The food manufacturer posted earnings per share of $0.

Eli Lilly shares rise on revenue beat, raised outlook
Proactive1h agobullish
Eli Lilly shares rise on revenue beat, raised outlook

Eli Lilly and Co (NYSE:LLY) shares rose nearly 7% in early trading Wednesday after the drugmaker reported second quarter results that topped Wall Street revenue expectations and raised its full-year 2026 revenue outlook, with strong demand for its Mounjaro and Zepbound weight-loss and diabetes...

Investing.com2h agobullish
AZN spikes 6% after report it denies AstraZeneca-BMS merger talks

AstraZeneca (NASDAQ: AZN) and Bristol Myers Squibb (NYSE: BMY) are the two directly affected public companies; AZN bears the most immediate price risk given it absorbed a roughly 9% single-day selloff on Monday when the merger speculation first emerged, while BMY shareholders were widely viewed as the primary beneficiaries of any combination.

This Week In Electric Vehicles - Battery Market's Billion-Dollar Surge Powers Global Growth
Simply Wall St.2h agobullish
This Week In Electric Vehicles - Battery Market's Billion-Dollar Surge Powers Global Growth

The global electric vehicle (EV) battery market is poised for significant growth, with projections indicating an increase from USD 103.04 billion in 2026 to USD 168.95 billion by 2035, driven by a compound annual growth rate of 5.6%. This expansion is fueled by the rising adoption of battery electric vehicles (BEVs), decreased battery pack prices, investments in local manufacturing, and advancements in fast-charging technologies and battery architectures. The 50-110 kWh battery capacity...